Q1 2025 Earnings Call Transcript February 10, 2025 Arrowhead Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-1.39 EPS, expectations were $-0.42. Chris Anzalone: Thanks, Vince.

In recent years, the conversation surrounding cannabis and its medicinal properties has gained considerable momentum.

Several risk tools can accurately predict individual baseline risks of adverse events in people with chronic kidney disease. Here, the authors examine methods of assessing risk and discuss risk ...

New EPA Administrator Lee Zeldin spoke with KTLA's Eric Spillman about the agency's efforts to provide federal aid to ...

We recently compiled a list of the 12 AI News and Ratings You Should Not Miss. In this article, we are going to take a look ...

Twelve new mpox vaccination sites have opened across England, health officials announced on Monday. The move, which comes ...

Despite the UKHSA stating that the risk of mpox is currently low, the UK is actively expanding access to mpox vaccines across ...

Another series of various novelties is already waiting for viewers in February. So without further ado, we invite you to get acquainted in more detail ...

We recently compiled a list of the Jim Cramer Shed Light on These 9 Stocks. In this article, we are going to take a look at ...

Crafted with professional athletes in mind, this cream offers effective relief for everyday muscle soreness and persistent chronic pain. The formula is made to aid in reducing stiffness ...

Cursed Objects are some of the most powerful yet dangerous ones, with the Monkey Paw being an especially tricky tool to use. You can generally find this item sitting on some kind of surface ...

Manual medicine therapy.These use gentle joint stretching as well as forceful mobilization to treat chronic pain. This type of therapy is usually done by a chiropractor or a physical therapist.